OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

GlobeNewswire Inc.

October 31, 2024 11:30AM GMT

WALTHAM, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professional (HCPs) and patients, will hold a conference call on Wednesday, November 13, 2024, at 4:30 p.m. Eastern Time to discuss its results for the third quarter period ended September 30, 2024. The financial results will be issued in a press release prior to the call.

OptimizeRx management will host the call, followed by a question-and-answer period. Details for the conference call can be found below:

 

 

Date:

Wednesday, November 13, 2024

Time:

4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)

Toll Free:

1-844-825-9789

International:

1-412-317-5180

Conference ID:

10193688

Call Me Link:

https://callme.viavid.com/?$Y2FsbG1lPXRydWUmcGFzc2NvZGU9JmluZm89Y29tcGFueSZyPXRydWUmYj0xNg==

Webcast:

https://viavid.webcasts.com/starthere.jsp?ei=1693210&tp_key=d77879d241

 

 

Please call the conference telephone number or log on to the web access link five minutes prior to the start time.

A replay of the call will remain available for 12 months via the Investors section of the OptimizeRx website at http://www.optimizerx.com/investors.  

AD

About OptimizeRx

OptimizeRx provides trailblazing technology that fosters care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the healthcare journey. With the ability to synchronize messaging across 2 million healthcare providers and over 240 million adults across a multitude of digital channels including a proprietary point-of-care network, OptimizeRx is changing the way life sciences engages with customers.

For more information, follow the Company on XLinkedIn or visit www.optimizerx.com.

OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
[email protected]

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
[email protected]

AD